公司資料
Evotec 股價、新聞與催化劑
- 股票代碼:
- EVO
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- Germany and listed in global markets with U
股票表現
1.65 USD (-3.80%)
收盤價
最後更新: 2026年10月1日
1.05B USD
市值
股價為何變動
截至 2026年10月1日，EVO 下跌 3.80%，收於 $1.65。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
Evotec is a drug-discovery and development platform company that supports pharma partners with research services and collaborative programs.
所在地與產業分類
Headquartered in Germany and listed in global markets with U.S. access, Evotec sits in discovery infrastructure.
商業模式特徵
The business combines service revenue, milestone economics, and collaborative drug-discovery partnerships.
生技產業定位
Evotec is part of the biotech R&D infrastructure layer, where partner demand and platform execution matter most.
未來催化劑
- Evotec's catalysts are discovery-partner deal flow, platform execution, and any asset monetization that improves the company’s capital structure. The market will watch whether the partnership engine can create more tangible value.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。